New treatment pathways for giant cell tumor of bone (GCTB) and chordoma make their debut in the updated version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for bone cancer, joining those for osteosarcoma, nonmetastatic
Search Results
Peter G. Shields
done in the clinic in just a few minutes,” Dr. Shields said. The goals of the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Smoking Cessation are to establish standards of care, facilitate implementation with clear guidelines
Presenter: Ronald S. Go
“Histiocytoses are rare diseases, and the annual incidences…are not exactly known,” revealed Ronald S. Go, MD, Associate Professor of Medicine, Mayo Clinic, Rochester, and panel chair of the NCCN Clinical Practice Guidelines in Oncology (NCCN
Kaylene Ready and Banu Arun
. Families such as these are often managed as if they have a known hereditary breast cancer syndrome, because the family history is so compelling. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment
Presenter: Aaron T. Gerds
expectancy, with an average time from diagnosis to death of approximately 5 to 6 years in all-comers,” he stated. Disease Risk Assessment Unlike many of the solid tumors represented in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), the
Philippe E. Spiess
Practice Guidelines in Oncology (NCCN Guidelines) for penile cancer, with input from experts in penile cancer from around the world. This comprehensive protocol is intended to establish a foundation to help standardize and optimize the care of patients
Leora Horn
Conference, joining maintenance chemotherapy and treatment of patients with acquired resistance to tyrosine kinase therapy with newer generation inhibitors. Chemotherapy: Histology Guides Choices According to the 2014 NCCN Clinical Practice Guidelines
Matthew Barth, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, Kimberly Davies, Hilda Ding, James B. Ford, Paul J. Galardy, Rabi Hanna, Robert Hayashi, Cathy Lee-Miller, Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Paul L. Martin, David McCall, Martha Pacheco, Anne F. Reilly, Mikhail Roshal, Sophie Song, Joanna Weinstein, Sara Zarnegar-Lumley, Nicole McMillian, Ryan Schonfeld, and Hema Sundar
adolescents. 7 This NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas provide recommendations for the diagnosis and management of pediatric patients with PMBL and sporadic variants of BL and
Ali Bazarbachi, Hamdy A. Azim, Hussain Alizadeh, Mahmoud Aljurf, Ibrahim Barista, Naeem A. Chaudhri, Zahira Fahed, Omar A. Fahmy, Ardeshir Ghavamzadeh, Mohamed H. Khalaf, Sami Khatib, Aghiad Kutoubi, Semra Paydas, Hanadi Rafii Elayoubi, Ghazi Zaatari, Hamdy M. Zawam, and Andrew D. Zelenetz
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and the 2008 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Hodgkin Lymphoma (to view the most recent version of these
Metastatic Breast Cancer, Version 1.2012
Featured Updates to the NCCN Guidelines
Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, Stephen B. Edge, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Steven Jay Isakoff, Britt-Marie E. Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth C. Reed, Mary Lou Smith, Hatem Soliman, George Somlo, Richard L. Theriault, John H. Ward, Antonio C. Wolff, Richard Zellars, Rashmi Kumar, and Dorothy A. Shead
Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include up-to-date guidelines for the clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, Phyllodes tumor, inflammatory breast caner, and breast cancer
